News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Howard S Hochster: Interesting phase 3 data on intraperitoneal therapy from China
Howard S Hochster/X
Jan 26, 2025, 14:56

Howard S Hochster: Interesting phase 3 data on intraperitoneal therapy from China

Howard S Hochster, Associate Director for Clinical Research at Rutgers Cancer Institute of New Jersey, shared a post on X:

“Interesting phase 3 data on intraperitoneal therapy from China GI25. Soon to be studied in EAONC STOPGAP study. Study lead by Dr Brett Ecker, Rutgers Cancer Institute soon.”

Howard S Hochster

Brett Ecker cancer Howard S Hochster OncoDaily Oncology
Special Coverage
Blog
Apr 3, 2025, 09:48
Mark Lythgoe: Great to be editors pick in The Lancet Oncology this month
Blog
Apr 3, 2025, 09:44
Colin Stirling: Flinders HealthCARE Centre – a game changer for our community
Blog
Apr 3, 2025, 09:43
Should NTCP models take the lead in radiation oncology treatment decisions? - ESTRO
Career
Apr 3, 2025, 09:39
Melvin Chua: Honoured to be Nominated as the Commissioner of the ICRU
Science
Apr 3, 2025, 09:29
Yan Leyfman: Ammonia - A Hidden Obstacle in Cancer Immunotherapy
Drugs
Apr 3, 2025, 09:27
Hidehito Horinouchi: Real-World Outcomes of Tarlatamab in SCLC
Blog
Apr 3, 2025, 09:16
Wafaa M Rashed: Submit your abstract for AORTIC 2025
Career
Apr 3, 2025, 09:14
Sarbajit Mukherjee: Thrilled to join Miami Cancer Institute as Chief of GI Medical Oncology
Science
Apr 3, 2025, 09:13
Myeloma Paper of the Day, April 3rd, suggested by Robert Orlowski
Insight
Apr 3, 2025, 09:04
Rami Manochakian: Honored to receive the 2025 Mayo Clinic Teacher Of The Year Award
Blog
Apr 3, 2025, 08:56
Lisa A. Lacasse: ACS CAN calls on the administration to reverse course and ensure sustained investment in tobacco control initiatives
Drugs
Apr 3, 2025, 08:53
Tian Zhang and Petros Grivas discussed best practices for Metastatic Urothelial Carcinoma Therapy